Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients

Aims  The aldose reductase (AR) gene, a rate‐limiting enzyme of the polyol pathway, has been investigated as a candidate gene in determining susceptibility to diabetic microangiopathy. However, the association of the AR gene with diabetic macroangiopathy has not been investigated. Therefore, the present study was conducted to determine whether genetic variations of AR may determine susceptibility to diabetic macroangiopathy.

• Publication year

  2006

• Venue

  Diabetic Medicine

• Publication date

  2006-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1464-5491.2006.01946.xPMID 16911628PMCID 1619898
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults

  2005cited by this paper
• C-106T Polymorphism in Promoter of Aldose Reductase Gene Is a Risk Factor for Diabetic Nephropathy in Type 2 Diabetes Patients with Poor Glycaemic Control

  2005cited by this paper
• Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes.

  2004cited by this paper
• Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes

  2004cited by this paper
• Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells.

  2004cited by this paper
• Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.

  2004cited by this paper
• Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes.

  2003cited by this paper
• Functional differences between the susceptibility Z-2/C-106 and protective Z+2/T-106 promoter region polymorphisms of the aldose reductase gene may account for the association with diabetic microvascular complications.

  2003cited by this paper
• The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy.

  2003cited by this paper
• Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications.

  2003cited by this paper
• C-106T polymorphism of AKR1B1 is associated with diabetic nephropathy and erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes mellitus.

  2003cited by this paper
• Genetic analysis of aldose reductase in diabetic complications.

  2003cited by this paper
• Aldose Reductase Mediates Mitogenic Signaling in Vascular Smooth Muscle Cells*

  2002cited by this paper
• Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity

  2001cited by this paper
• Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus

  2001cited by this paper
• Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus

  2000cited by this paper
• An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-β receptor in cultured rat aortic smooth muscle cells

  1999cited by this paper
• A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.

  1999cited by this paper
• An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-beta receptor in cultured rat aortic smooth muscle cells.

  1999cited by this paper
• An aldose redutase inhibitor prevents the intimal thickening in coronary arteries of galactose-fed beagle dogs

  1999cited by this paper
• Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications.

  1998cited by this paper
• Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells

  1997cited by this paper
• Identification and Characterization of Multiple Osmotic Response Sequences in the Human Aldose Reductase Gene*

  1997cited by this paper
• Characterization of the osmotic response element of the human aldose reductase gene promoter.

  1996cited by this paper
• Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose.

  1995cited by this paper
• Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells.

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group.

  1992cited by this paper
• Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus

  1990cited by this paper

• Effects of High Glucose on Simulated Ischemia/Reperfusion Injury in Isolated Cardiomyocytes

  2025cites this paper
• Comparative anti-Diabetic potential of phytocompounds from Dr. Duke's phytochemical and ethnobotanical database and standard antidiabetic drugs against diabetes hyperglycemic target proteins: an in silico validation

  2023cites this paper
• The relationship between AKR1B1 rs759853 (C-106T) polymorphism and the diabetic retinopathy severity in Turkish Type 2 diabetes mellitus patients

  2022cites this paper
• Rationale and Design of the Aldose Reductase Inhibition for Stabilization of Exercise Capacity in Heart Failure Trial (ARISE-HF) in Patients with High-Risk Diabetic Cardiomyopathy.

  2022cites this paper
• PPARɣ2, aldose reductase, and TCF7L2 gene polymorphisms: relation to diabetes mellitus

  2022cites this paper
• Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications

  2021cites this paper
• A New Symmetrical Thiazolidinedione Derivative: In Silico Design, Synthesis, and In Vivo Evaluation on a Streptozotocin-Induced Rat Model of Diabetes

  2021cites this paper
• Characterization of lncRNA and mRNA profiles in rats with diabetic macroangiopathy

  2020cites this paper
• Changes in serum inflammatory factor interleukin-6 levels and pathology of carotid vessel walls of rats with chronic periodontitis and diabetes mellitus after the periodontal intervention

  2020cites this paper
• Sorbinil, an Aldose Reductase Inhibitor, in Fighting Against Diabetic Complications.

  2019cites this paper
• Polymorphisms of Aldose Reductase (ALR2) Regulatory Gene are Risk Factors for Diabetic Retinopathy in Type-2 Diabetes Mellitus Patients in Bali, Indonesia

  2018cites this paper
• Association of aldose reductase gene polymorphism (C-106T) in susceptibility of diabetic peripheral neuropathy among north Indian population.

  2017cites this paper
• Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities

  2016cites this paper
• Association of aldose reductase gene (AKR1B1) polymorphism with diabetic retinopathy.

  2016cites this paper
• Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients

  2016influential citation
• Aldose reductase C-106T polymorphism is associated with the risk of essential hypertension.

  2016cites this paper
• Identifying Common Genetic Risk Factors of Diabetic Neuropathies

  2015cites this paper
• Aldose Reductase and Diabetic Cardiovascular Disease

  2014cites this paper
• Association of C(-106)T polymorphism in aldose reductase gene with diabetic retinopathy in Chinese patients with type 2 diabetes mellitus.

  2014cites this paper
• Role of aldose reductase C-106T polymorphism among diabetic Egyptian patients with different microvascular complications

  2014cites this paper
• Aldose Reductase Meets Histone Acetylation: A New Role for an Old Player

  2014cites this paper
• Molecular and Cellular Signaling Mechanisms Elucidating Aldose Reductase Mediated Ischemia-Reperfusion Injury in the Myocardium

  2012cites this paper
• Genetics of Endothelial Damage Associated to Diabetes Mellitus Type 2

  2011cites this paper
• More severe type 2 diabetes‐associated ischemic stroke injury is alleviated in aldose reductase‐deficient mice

  2010cites this paper
• Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.

  2010cites this paper
• Diabetic retinopathy and systemic vascular complications.

  2008cites this paper
• Current literature in diabetes

  2007cites this paper
• The Diabetic II Neuropathy and the Gene Polymorphism in the P636 Temperature Regulations

  year unknowncites this paper
• Central European Journal of Biology Gene Polymorphisms in Patients with Type 2 Diabetes and Diabetic Nephropathy

  year unknowncites this paper